Auditing and Reporting
Using EPCS Gold alone or in combination with Imprivata Confirm ID supports detailed reporting to establish a secure, auditable chain of trust for the entire EPCS process. This will help your organization prove compliance with DEA requirements.
e-Prescribing combined with biometric authentication allows customers to provide their physicians with the most convenient workflow to e-prescribe controlled substances. MEDITECH collaborates with DrFirst and Forward Advantage to address market and compliance-driven requirements such as these. With years of successful delivery of e-prescribing through DrFirst and advanced authentication technologies created by Imprivata and delivered by Forward Advantage, we are well positioned to collectively support all components of controlled substance e-prescribing.
To meet requirements for two-factor authentication at the time of prescribing, EPCS Gold includes provision of hard or so one-time-password tokens. For optimal workflow, Imprivata Confirm ID enables the use of fingerprint biometric identification that meets FIPS-201 Personal Identity Verification requirements. This gives providers the flexibility to use the two-factor authentication process they prefer for ease of use and convenience when prescribing inside or outside the hospital.